Exosomal noncoding RNAs in prostate cancer

Area of Science:

• Oncology
• Molecular Biology
• Biomarker Discovery

Background:

• Prostate cancer (PCa) is a leading cause of cancer mortality in men.
• Current PCa biomarkers have limitations, including false-positive results.
• Exosomal non-coding RNAs (ncRNAs) are emerging as promising diagnostic markers.

Purpose of the Study:

• To review the role of ncRNAs in PCa initiation and progression.
• To focus on exosomal ncRNAs as potential PCa biomarkers.
• To identify specific exosomal miRNAs and lncRNAs for PCa diagnosis.

Main Methods:

• Literature review of research on ncRNAs in prostate cancer.
• Analysis of studies identifying exosomal miRNAs and lncRNAs in various bodily fluids.
• Compilation of specific exosomal ncRNAs reported for PCa diagnosis.

Main Results:

• Identified 8 plasma exosomal miRNAs, 19 urine exosomal miRNAs, 2 serum miRNAs, and 5 semen miRNAs for PCa diagnosis.
• Highlighted 4 exosomal lncRNAs in plasma and urine as potential PCa biomarkers.
• Exosomal ncRNAs reflect the state of the originating cancer cells.

Conclusions:

• Exosomal ncRNAs, including miRNAs and lncRNAs, are crucial in PCa development.
• Specific exosomal ncRNAs demonstrate significant potential as non-invasive biomarkers for PCa detection.
• Further research into exosomal ncRNAs can improve PCa diagnostics and patient outcomes.